Deccan Health Care (ISIN: INE452W01019) has announced a significant change in its leadership team. The company's Company Secretary and Compliance Officer, Ronak Darji, has tendered his resignation, which has been accepted by the board with immediate effect.

Key Points

• Resignation: Ronak Darji has stepped down from his position as Company Secretary and Compliance Officer.
• Effective Date: The resignation is effective from the close of business hours on December 1, 2025.
• New Appointment: Mohita Gupta, the current Chief Operating Officer (COO), has been appointed as the designated Compliance Officer to fill the vacancy.

This change in the company's key managerial personnel comes at a time when Deccan Health Care has been showing steady growth in its financial position. Based on the most recent balance sheet data:

Financial Highlights

The company's financial position shows growth across key metrics, with a notable increase in total assets and current assets. However, there's also a significant rise in current liabilities, which investors may want to monitor.

The appointment of the COO, Mohita Gupta, as the new Compliance Officer suggests that Deccan Health Care is leveraging its existing leadership to ensure a smooth transition in this crucial role. This move may help maintain continuity in the company's compliance and regulatory affairs.

As Deccan Health Care navigates this leadership transition, stakeholders will likely be keen to observe how these changes might impact the company's operations and strategic direction in the coming months.

Deccan Health Care has reported strong financial performance for the second quarter, demonstrating significant growth in both revenue and profitability.

Financial Highlights

The company's standalone revenue for Q2 reached ₹2,440.46 lakh, marking a substantial 29.7% increase year-over-year. This growth was primarily driven by product diversification and digital expansion strategies. The net profit for the quarter stood at ₹89.97 lakh, representing a remarkable 67.5% surge compared to the same period last year.

Improved Profitability

Deccan Health Care has significantly enhanced its profitability, with the EBITDA margin improving to 7.0% from 3.4% in the previous year. This improvement reflects the company's focus on operational efficiency and cost management.

Half-Year Performance

For the first half of FY2025-26, Deccan Health Care reported:

• Standalone revenue of ₹4,587.41 lakh, up 35.4% YoY
• Half-yearly PAT of ₹111.22 lakh, an increase of 22.8% YoY

Strategic Initiatives

The company has broadened its wellness portfolio with innovative product launches, including:

• EnergyDecc™
• SlimDecc™
• Reactive Go Advanced
• New range of functional fruit bars and gummies

Deccan Health Care has also introduced a Weight Wellness Program, focusing on metabolic balance, vitality, and holistic well-being through three synergistic formulations.

Global Expansion

The company is actively pursuing international growth:

• Regulatory approvals filed in 6 international markets
• Product launches in UAE and GCC planned for March 2026

Management Commentary

Mr. Mohak from Deccan Health Care stated, "Our Q2 performance demonstrates the resilience of our model and rising consumer preference for preventive, scientific wellness. We remain focused on disciplined execution, export-readiness, and sustained long-term value creation."

Outlook

With its strong financial performance, product innovation, and international expansion plans, Deccan Health Care appears well-positioned for continued growth in the preventive healthcare and wellness sector. The company's focus on science-backed formulations and strategic market expansion may contribute to its future success in both domestic and international markets.

Investors and stakeholders will likely keep a close eye on Deccan Health Care's ability to maintain this growth trajectory and successfully execute its expansion plans in the coming quarters.